The class of chemical compounds known as PP2A-Aα inhibitors pertains to a specialized group that effectively targets and modulates the functionality of the protein phosphatase 2A (PP2A) enzyme, specifically through its Aα subunit. With a widespread presence, PP2A holds indispensable status as a serine/threonine phosphatase that governs crucial cellular signal transduction and regulatory pathways. Playing a pivotal role, the Aα subunit of PP2A serves as a pivotal scaffold, orchestrating the assembly of the active holoenzyme complex and orchestrating its interactions with diverse regulatory and targeting components. Functionally, PP2A-Aα inhibitors operate by disrupting this regulatory role, thereby inducing alterations in the enzyme's capacity to effectively dephosphorylate key substrates and actively participate in vital cellular processes.
The distinctive structural makeup of PP2A-Aα inhibitors underscores their ability to selectively bind to the PP2A enzyme's Aα subunit. This binding interaction manifests through a range of chemical mechanisms, such as hydrogen bonding, hydrophobic interactions, and electrostatic forces. The ensuing conformational changes within the enzyme's active site, prompted by the binding of these inhibitors, ultimately lead to significant modifications in catalytic activity and substrate recognition. Consequently, the influence of PP2A-Aα inhibitors cascades down to impact a diverse array of cellular functions, spanning from the regulation of gene expression, cell cycle progression, and apoptosis to the dynamic rearrangements of the cytoskeleton. This class of inhibitors thus serves as indispensable tools for the meticulous exploration of PP2A's intricate regulatory networks and its far-reaching involvement in maintaining cellular equilibrium.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
Cantharidin binds to PP2A-Aα and interferes with the catalytic activity of the enzyme, leading to altered protein dephosphorylation and downstream signaling. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits PP2A-Aα by binding to its catalytic subunit, preventing dephosphorylation of target proteins and leading to disrupted cellular signaling. | ||||||
Fostriecin | 87860-39-7 | sc-202160 | 50 µg | $265.00 | 9 | |
Fostriecin binds to the PP2A catalytic subunit and inhibits its phosphatase activity, resulting in dysregulated phosphorylation events and altered cellular processes. | ||||||
LB-100 | 1632032-53-1 | sc-507368 | 10 mg | $330.00 | ||
LB-100 inhibits PP2A-Aα through binding to its catalytic subunit, disrupting its phosphatase activity and affecting cell cycle progression and apoptosis. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits PP2A-Aα by interacting with its catalytic subunit, leading to aberrant phosphorylation patterns and perturbed cellular functions. | ||||||
Cercosporamide | 131436-22-1 | sc-202095 sc-202095A | 500 µg 2.5 mg | $306.00 $1224.00 | 2 | |
Cercosporamide disrupts PP2A-Aα function by binding to its catalytic subunit, causing dysregulated phosphorylation events and impacting cell cycle progression. | ||||||
Cantharidic Acid | 28874-45-5 | sc-201323 sc-201323A | 10 mg 50 mg | $104.00 $353.00 | 1 | |
Cantharidic Acid inhibits PP2A-Aα by binding to its catalytic subunit, resulting in altered protein dephosphorylation and modulation of various cellular processes. | ||||||
Norcantharidin | 29745-04-8 | sc-280719 | 5 g | $113.00 | 2 | |
Norcantharidin inhibits PP2A-Aα by interfering with its catalytic activity, leading to disrupted protein dephosphorylation and effects on cell cycle control. | ||||||
Cilengitide | 188968-51-6 | sc-507335 | 5 mg | $215.00 | ||
Cilengitide interacts with PP2A-Aα and modulates its activity, leading to altered phosphorylation events and influencing cellular processes such as angiogenesis and apoptosis. | ||||||